WFDC2 and ovarian carcinoma: While HE4 has been extensively studied as a biomarker for ovarian cancer,6, 7, 8 researchers such as Bingle et al. have shown its expression in various locations, including the oral cavity, nasopharynx, respiratory tract, salivary glands, and lungs, highlighting its broad tissue distribution in 2006.9